Join the Conversation

Deal between schools and DowDuPont opens up CRISPR's potential

CLOSE

A patent deal between DowDuPont and Ivy League scientists gives the company room to tinker with the full breadth of the promising gene-modification tool called CRISPR.
10/27/17
Damian Giletto/The News Journal